Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines
(Q28216281)
scientific article (publication date: 22 January 2002)
scientific article (publication date: 22 January 2002)
Language:
| (P31) |
(Q13442814)
|
||||||||||||||||||
| (P304) |
169-78
|
||||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||||
| (P433) |
2
|
||||||||||||||||||
| (P478) |
58
|
||||||||||||||||||
| (P577) |
Tuesday, January 22, 2002
|
||||||||||||||||||
| (P921) |
(Q8277)
|
||||||||||||||||||
| (P1433) |
(Q1161692)
|
||||||||||||||||||
| (P1476) |
"Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines" (language: en)
|
||||||||||||||||||
| (P2093) |
D S Goodin
E M Frohman
G P Garmany
J Halper
W H Likosky
F D Lublin
D H Silberberg
W H Stuart
S van den Noort
|